Literature DB >> 24337673

[Radiotherapeutic concepts in cancer of unknown primary site].

D Krug1, J Debus, F Sterzing.   

Abstract

BACKGROUND: The term cancer of unknown primary (CUP) encompasses a group of entities which differ to a great extent regarding etiology, prognosis and therapeutic management.
OBJECTIVES: The aim of the study was an elaboration of the role of radiotherapy in CUP syndrome.
MATERIAL AND METHODS: Systematic literature search and specification of the available treatment options.
RESULTS: Radiotherapy is an integral part of interdisciplinary management approaches for patients with CUP in both curative and palliative situations. Radio-oncological techniques, such as intensity-modulated radiotherapy and stereotactic body radiotherapy increase the therapeutic window. Modern diagnostic modalities from radiology and nuclear medicine are the cornerstone of radiotherapeutic interventions, especially in terms of target volume definition and pretherapeutic staging. In the interdisciplinary setting radiation oncology offers the possibility of curative and often organ preserving approaches in patients with axillary and cervical CUP. In addition, improvement and preservation of quality of life can be achieved in patients with metastatic disease.
CONCLUSION: Radiation oncology is a crucial component of the interdisciplinary management of patients with CUP. Therapeutic decisions in patients with CUP should be made in an interdisciplinary setting.

Entities:  

Mesh:

Year:  2014        PMID: 24337673     DOI: 10.1007/s00117-013-2550-1

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  28 in total

Review 1.  Cancer of unknown primary: does treatment modality make a difference?

Authors:  Ashley E Balaker; Elliot Abemayor; David Elashoff; Maie A St John
Journal:  Laryngoscope       Date:  2012-04-26       Impact factor: 3.325

2.  Brain metastases from unknown primary tumour: a prospective study.

Authors:  R Rudà; M Borgognone; F Benech; E Vasario; R Soffietti
Journal:  J Neurol       Date:  2001-05       Impact factor: 4.849

3.  Radiotherapeutic management of cervical lymph node metastases from an unknown primary site.

Authors:  Stephanie M Perkins; Christopher R Spencer; Rebecca D Chernock; Bruce H Haughey; Brian Nussenbaum; Douglas R Adkins; David I Kuperman; Wade L Thorstad
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-07

4.  Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases.

Authors:  G Vlastos; M E Jean; A N Mirza; N Q Mirza; H M Kuerer; F C Ames; K K Hunt; M I Ross; T A Buchholz; A U Buzdar; S E Singletary
Journal:  Ann Surg Oncol       Date:  2001-06       Impact factor: 5.344

5.  Survival in cancer of unknown primary site: population-based analysis by site and histology.

Authors:  K Hemminki; M Bevier; A Hemminki; J Sundquist
Journal:  Ann Oncol       Date:  2011-11-24       Impact factor: 32.976

6.  Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.

Authors:  Allen M Chen; Bao-Qing Li; D Gregory Farwell; Joseph Marsano; Srinivasan Vijayakumar; James A Purdy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

7.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

8.  Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.

Authors:  Dirk Rades; Fabian Fehlauer; Theo Veninga; Lukas J A Stalpers; Hiba Basic; Peter J Hoskin; Volker Rudat; Johann H Karstens; Steven E Schild; Juergen Dunst
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-02       Impact factor: 7.038

Review 9.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

10.  Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.

Authors:  Indira Madani; Luc Vakaet; Katrien Bonte; Tom Boterberg; Wilfried De Neve
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-06       Impact factor: 7.038

View more
  1 in total

Review 1.  CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.

Authors:  Gregor Zaun; Martin Schuler; Ken Herrmann; Andrea Tannapfel
Journal:  Dtsch Arztebl Int       Date:  2018-03-09       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.